Brookstone Capital Management »

Catalyst Pharmaceutical Partners shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $534k 34k 15.94
2023-12-31 $563k 34k 16.81
2023-09-30 $433k 34k 12.95
2023-06-30 $455k 37k 12.33
2023-03-31 $605k 34k 18.08
2022-12-31 $657k 34k 19.60
2022-09-30 $415k 34k 12.40
2021-06-30 $91k 17k 5.52
2021-03-31 $71k 15k 4.61

More positions owned by Brookstone Capital Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Northern Lts Fd Tr Iv Brookstone Grwth (BAMG)
Northern Lts Fd Tr Iv Brookstone Value (BAMV)
Northern Lts Fd Tr Iv Brookstone Divid (BAMD)
Microsoft Corporation (MSFT)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)

View all positions for Brookstone Capital Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners